clofutriben
AssetAlso AS-2473662, ASP-3662, HDD-1697, SPI-62
Inhibitor of 11beta-hydroxysteroid dehydrogenase type 1, lowering intracellular cortisol regeneration.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Cortisol excess
Phase 2, Recruiting, NCT07296484, clinicaltrials.gov, 7 Oct 2026
Type 2 diabetes
Phase 2, Recruiting, NCT07296484, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors12
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.